New Egypt, NJ, United States of America

Jeffrey N Clark

This inventor holds 2 USPTO granted patents. Top assignee: Schering Corporation. Active years: 1987-1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey N Clark. Retrieved from https://idiyas.com/inventor/jeffrey-n-clark-n2mzp5ir

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1987-1988

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jeffrey N. Clark

Introduction

Jeffrey N. Clark is an accomplished inventor based in New Egypt, New Jersey. With a keen focus on developing anthelmintic solutions, he holds two patents that significantly contribute to the field of organic chemistry. His inventive spirit aligns well with the mission of advancing health and wellness through innovative pharmaceuticals.

Latest Patents

Jeffrey's recent patents focus on organic acid-substituted guanidine compounds designed for use as anthelmintics. The first, titled "Organic acid-substituted guanidine anthelmintics," encompasses an extensive exploration of these compounds, including methods for their preparation and application. Similarly, his second patent, "N-((2-nitro)phenyl)-N' (organic acid) guanidine anthelmintics," reiterates the importance of these compounds and their potential therapeutic uses.

Career Highlights

Throughout his career, Jeffrey has been affiliated with the Schering Corporation, where his work focuses on pharmaceutical innovations. His dedication to advancing medical science is evident through his contributions to the development of new treatments.

Collaborations

Jeffrey's journey in innovation is enhanced through collaboration with talented individuals such as Dhiru B. Vashi and Neil A. Lindo. These partnerships encourage a dynamic exchange of ideas, pushing the boundaries of what is possible in pharmaceutical research.

Conclusion

In conclusion, Jeffrey N. Clark's work in the realm of organic acid-substituted guanidine compounds showcases his dedication to innovation. Through his patents and collaborations, he is contributing to the future of effective anthelmintic therapies, making a significant impact within the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…